Benefits of Partnering with Organizations on System Evaluation

Stephanie Harden

,
Reading Time: 2 minutes
two women in lab coats speaking

For contract organizations working in the pharmaceutical industry, operating at peak performance and capacity is a vital step towards delivering life-saving therapies. It is vital for these companies to maintain their instruments, and additionally important to establish consistency across both their systems and vendors before making an upgrade.

Eurofins BioPharma Product Testing division (BPT), Toronto based in Canada, contracts with some of the world’s largest pharmaceutical, biopharmaceutical, and medical device companies. They provide chemical, microbial, stability, and sterility testing on a vast array of products ranging from raw materials to finished products. The company recently collaborated with Waters to assess the risk and impact around introducing modern HPLC technology for their validated analytical test methods.

Eurofins BPT Toronto understands that they must demonstrate to their clients that they can provide quality data in a timely manner, while actively managing their high-performance liquid chromatography (HPLC) fleet in order to minimize any possible downtime due to mechanical issues.

two women in lab coats speaking

The Quality By Design Process

Taking a risk-based approach with Waters helped Eurofins BPT Toronto to better understand the differences between their old and new options. During this process, the Waters team helped the organization:

  • Understand the key considerations when upgrading their assets
  • Focus on the relevant performance and technical aspects of the instrument specifications
  • Predict the impact of a new instrument on the analytical procedure performance
  • Proactively prevent issues due to instrument differences through application of appropriate control strategies.

Dr. Douglas Turk, Business Unit Manager at Eurofins BPT Toronto, explains:

We’re always offering new services and that often gets a new client in the door. That’s why we were interested in this risk-based analysis for method migration. We are always looking for opportunities to improve our business and this quality by design approach for legacy method migration to newer HPLC platforms is a very useful tool in our toolbox.

Download the case study now to read more about how Eurofins BPT Toronto evaluated a new Waters system to confidently make decisions about their instrument replacement strategy.